EDITOR'S LETTER

EYE ON CHINA

• Mab-Venture Biopharma & Thermo Fisher Establish Asia Pacific's First "SmartFactory" for Antibody Drugs
• Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era of Interventional Cardiology in China
• Key Diabetes Receptor Structure Determined by International Collaboration
• China Sets Up National Lab Developing Brain-Like AI Technology
• Chinese Scientists Realize On-site Drug Detection
• Scientists Map Single-Copy HIV-1 Provirus Loci in Human Chromosomes in Live Host Cells
• Gene Variant Explains Differences in Blood Fatty Acid Levels
• Scientists Illustrate How Host Cell Responds to Zika Virus Infection

HONG KONG News

• Uni-Bio Science Launches Best-in-Class Oral Anti-Diabetic Drug Mitiglinide Branded
• “博康泰®”(Bokangtai)

FEATURES

• Shire Championing the Cause for Patients with Rare Diseases
• ASEAN⁺ Rare Disease Network: Unifying Voices of Patients
• Rainbow Across Borders
• Genetic Counselling Services in Malaysia

SPOTLIGHTS

• Cancer Control Efforts in Vietnam: Interview with Dr Tran Thanh Huong
• Prof. Jackie Y. Ying, a Leader in Nanotechnology
• Exclusive Interviews with Innovators Under 35

COLUMNS

• New Womb-Like Invention for Preterm Infants
• Reversing Paralysis: Can I Walk Again?

INSIDE INDUSTRY

• NUS Researchers Create Palm-Size Device for Quick, Effective Treatment of Common Hearing Disorder
• World Asthma Day: Managing and Living with Asthma
• DARZALEX® (daratumumab) Available in Singapore, Following Accelerated Approval by the Health Sciences Authority
• Managing Liver Cancer as a Global Health Problem
• Bayer and NUS Enterprise Announce Winners of Grants4Apps® Singapore Open Innovation Challenge
• Exclusive Interviews with the Grants4Apps® winners: EyeDEA (SG), GlycoLeap by Holmusk (SG) and PillPocket (Thailand)

BIOBOARD

JAPAN

• Asia Pacific Medical Technology Association (APACMed) announces partnership with Japan Federation of Medical Devices Associations (JFMDA)

UNITED STATES